Search
ASHG 2017 DAY 4: CRISPR/CAS9 TARGETING AND STRUCTURAL VARIANT CALLING COLABS
It was a packed house as PacBio scientists led the inaugural CoLabs presentation at ASHG17 A new program at ASHG this year came from...
CLINICAL TRIAL LAB INTRINSIC IMAGING JOINS RISE OF AI IN RADIOLOGY
San Antonio - Algorithms are now a silent, ever-present part of life, turning the wheels that operate our favorite apps, games, television...
BIO ROUNDUP: KITE'S CAR-T APPROVED, OBAMACARE FIX & LILLY MRNA DEAL
Kite Pharma wasn't expecting a regulatory decision for its non-Hodgkin lymphoma treatment until November, but this week, the company...
ASHG DAY 2: POPULATION AND CLINICAL GENETICS, PLUS A SMRT SEQUENCING ROADMAP
The PacBio team hosted a luncheon workshop at ASHG yesterday titled “Population and Clinical Genetics Studies Using Long-read SMRT...
U.K. HEALTH CARE SYSTEM MAY DENY SURGERY TO SMOKERS AND THE OBESE
A new plan by the Hertfordshire clinical commissioning groups of the U.K.'s national health care system, the NHS, will deny surgery...
BOSTON BIOMEDICAL ASSOCIATES TO PRESENT AT THE 2017 OUTSOURCING IN CLINICAL TRIALS ISRAEL CONFERENCE IN MARCH
Tami Abudi, Co-CEO of BBA Ltd. presents on outlining global considerations in First-In-Human clinical trials at the Arena Outsourcing...
FLUID BOLUS OVER 15-20 VERSUS 5-10 MINUTES EACH IN THE FIRST HOUR OF RESUSCITATION IN CHILDREN WITH SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL*
Objectives: To compare the effect of administration of 40-60 mL/kg of fluids as fluid boluses in aliquots of 20 mL/kg each over 15-20...
VIR BIOTECH VIES FOR GLOBAL APPROACH TO TACKLING INFECTIOUS DISEASE
Vir Biotechnology CEO George Scangos aims to develop new infectious disease drugs that can treat people in the U.S. and other developed...
ELI LILLY TO PURSUE MRNA CANCER VACCINES WITH CUREVAC PACT
Eli Lilly is getting a foothold in messenger RNA cancer vaccines through a deal with CureVac that could develop up to five new therapies....
GEMINI REELS IN $42M TO TARGET ROOT CAUSES OF AGE-RELATED BLINDNESS
One of the biggest risk factors for vision loss is age. As people grow old, the central part of the retina can become damaged, leading...
ANTIBIOTIC EXPOSURE AND INTERPERSONAL VARIANCE MASK THE EFFECT OF IVACAFTOR ON RESPIRATORY MICROBIOTA COMPOSITION
Publication date: Available online 15 October 2017 Author(s): Anton Y. Peleg, Jocelyn Choo, Katherine Langan, Deirdre Edgeworth, Dominic...
DON'T MISS YOUR CHANCE TO SAVE ON HEALTHCARE + A.I. ON NOV. 2
In just a few weeks, Xconomy is going to host our newest event, Healthcare + A.I. , at Pfizer's offices in Cambridge, MA. The Nov....
PHRIXUS TO LAUNCH CLINICAL TRIALS FOR DUCHENNE DRUG IN EARLY 2018
After showing some early promise in treating European patients, Ann Arbor, MI-based Phrixus Pharmaceuticals , a startup developing...
SEX ADDICTION IS A MYTH - WHATEVER THE FAMOUS SAY
No sooner had the news about Harvey Weinstein's sexual assault allegations broke than he was claiming to be addicted to sex and checking...
TEMPORARY SENIOR RESEARCH ASSOCIATE, MOLECULAR
Agena Bioscience is a company dedicated to improving healthcare through revolutionary genetic analysis solutions. Agena is on the forefront...
INSULIN PUMPS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES
The use of insulin pumps for intensive insulin therapy among young patients with type l diabetes has increased substantially in recent...
PHASE 2 CLINICAL TRIALS OF TWO CANDIDATE EBOLA VACCINES IN LIBERIA
A phase 2 clinical trial of two candidate Ebola vaccines in Liberia showed that the vaccines are safe and response lasts at least for...